More tools:Markets·Screener·Research·Chat

Tiziana Life Sciences Ltd. Common Shares (TLSA) Financial Statements

Tiziana Life Sciences Ltd. Common Shares
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG0129Q42Y1
XNAS · usd
0.99▼ 0.03 (-2.97%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt—
Trading Information
Previous Close1.02
Day's Range0.96 – 1.03
52-Week Range0.87 – 2.35
Volume908.2K
Avg Volume930.6K
Share Statistics
Shares Outstanding
Employees9
ExchangeXNAS
Listed2018-11-20
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Tiziana Life Sciences Ltd. Common Shares (TLSA)
What is Tiziana Life Sciences Ltd. Common Shares's Market Cap?
Tiziana Life Sciences Ltd. Common Shares's Market Cap is $119.3M, based on as-reported figures from SEC (XBRL) filings.
What is Tiziana Life Sciences Ltd. Common Shares's Net Income (TTM)?
Tiziana Life Sciences Ltd. Common Shares's Net Income (TTM) is -$18.4M, based on as-reported figures from SEC (XBRL) filings.
What is Tiziana Life Sciences Ltd. Common Shares's EBITDA?
Tiziana Life Sciences Ltd. Common Shares's EBITDA is -$21.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tiziana Life Sciences Ltd. Common Shares's Diluted EPS (TTM)?
Tiziana Life Sciences Ltd. Common Shares's Diluted EPS (TTM) is -0.15, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Operating Expenses
Research and Development
Operating expenses
Total operating expenses
Loss from operations
Finance and Other income/(expense):
Finance income
FV Gain/(Loss) on Investment
Gain/on sale of Investment
Total other income/(expense)
Loss from operations before income taxes
Income tax credit/(expense)—
Loss for the year
Other Comprehensive loss:
Gain/(Loss) on currency translation
Comprehensive loss
Basic loss per share attributable to common shareholders (in Dollars per share)
Diluted loss per share attributable to common shareholders (in Dollars per share)